- Rivaroxaban Intermediate
- 4-(4-Aminophenyl)morpholin-3-one
- (S)-2-(oxiran-2-ylmethyl) isoindoline-1,3-dione (or) (S)-Glycidyl Phthalimide
- 5-Chlorothiophene-2-Carboxylic Acid
- 2-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl) phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione
2-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl) phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione
![2-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl) phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione](assets/images/products/cas-446292-08-6-thumb.png)
| API Name | Rivaroxaban Intermediate |
| Intermediate Name | 2-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl) phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione |
| CAS No. | 446292-08-6 |
| Stage | R&D |
Disclaimer
I - Products protected by patents are developed solely for the R&D purpose intended to support regulatory submissions.
II - It is within the buyer's responsibility and liability to check the patent situation of the products in the import market(s).
I - Products protected by patents are developed solely for the R&D purpose intended to support regulatory submissions.
II - It is within the buyer's responsibility and liability to check the patent situation of the products in the import market(s).
